1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Delayed London Stock Exchange  -  05/20 11:35:10 am EDT
10494.00 GBX   +2.38%
05:06aAstrazeneca's Healthy Heart Africa Screens 3.9 Million Ugandans for Hypertension
AQ
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/19ASTRAZENECA : Deutsche Bank gives a Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Investor's Net Asset Value Jumps 41% in 2021 As Low Interest Rate Environment Uplifts Returns

01/21/2022 | 04:47am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 2.38% 10494 Delayed Quote.18.11%
ERICSSON -0.01% 77.62 Delayed Quote.-22.21%
All news about ASTRAZENECA PLC
05:06aAstrazeneca's Healthy Heart Africa Screens 3.9 Million Ugandans for Hypertension
AQ
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/19ASTRAZENECA : Deutsche Bank gives a Buy rating
MD
05/18Kepler Cheuvreux Downgrades AstraZeneca to Hold From Buy
MT
05/18Kepler Cheuvreux Drops AstraZeneca To Hold From Buy, Lifts PT
MT
05/18AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies aga..
AQ
05/18From storage to transport, hurdles to getting COVID vaccine to N.Koreans
RE
05/17What you need to know about the coronavirus right now
RE
05/17ASTRAZENECA : Deutsche Bank keeps its Buy rating
MD
05/17AstraZeneca Obtains Exclusive Global License To Develop Antibodies Against COVID-19
MT
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 43 737 M - -
Net income 2022 5 294 M - -
Net Debt 2022 22 519 M - -
P/E ratio 2022 37,5x
Yield 2022 2,30%
Capitalization 199 B 198 B -
EV / Sales 2022 5,05x
EV / Sales 2023 4,64x
Nbr of Employees 83 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 128,15 $
Average target price 143,15 $
Spread / Average Target 11,7%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC18.11%198 562
JOHNSON & JOHNSON2.59%457 706
PFIZER, INC.-14.23%284 192
ABBVIE INC.12.05%268 106
ROCHE HOLDING AG-16.41%265 188
ELI LILLY AND COMPANY3.64%257 689